Correspondence: circadian melatonin rhythms in critically ill patients with delirium - Summary - MDSpire

Correspondence: circadian melatonin rhythms in critically ill patients with delirium

  • By

  • Danielle Hunziker

  • Tatjana Zehnder

  • Madlaina Forster

  • Anna Estermann

  • Núria Zellweger

  • Jan Huber

  • Andrea Blum

  • Salim Abdelhamid

  • Fenna Stolte

  • Lua Maria Mengisen

  • Christian Cajochen

  • Vitaliy Kolodyazhniy

  • Martin Siegemund

  • Alexa Hollinger

  • April 10, 2026

  • 0 min

Share

Objective:

To analyze circadian melatonin rhythms in delirious versus non-delirious ICU patients to explore potential melatonin treatment for delirium prevention and treatment, and its implications for clinical practice.

Approach:
    Key Findings:
    • Delirious patients exhibited a delayed Melatonin Onset (23.8 vs. 22.5, p = 0.035) and Midpoint Time (5.2 vs. 3.9, p = 0.023) compared to non-delirious patients.
    • No significant differences were found in Melatonin Offset (p = 0.054) and Amplitude (p = 0.10), highlighting the need for cautious interpretation.
    • Higher SOFA scores correlated with later melatonin midpoint times (r = 0.37, p = 0.018).
    Interpretation:

    The study indicates significant alterations in circadian melatonin rhythms in delirious ICU patients, suggesting potential for melatonin treatment to normalize these rhythms and influence future research directions.

    Limitations:
    • Small sample size may limit generalizability.
    • Heterogeneity in patient medical history not fully accounted for in matching.
    • Repeated nocturnal sampling could disrupt patient sleep, and the ICU environment may also impact patient responses.
    Conclusion:

    Findings support the hypothesis that melatonin or its analogues may help in preventing or treating delirium, but further research is needed to confirm these results and explore practical applications.

Original Source(s)

Related Content